Crescendo Bioscience, Inc.
Part of Myriad Genetics Inc.
- UEI
- KJ1FJFKF1PM9
- CAGE
- 488Y3
- Primary NAICS
- 621511 Medical Laboratories
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- Corporate family
-
-
Parent
Salt Lake City, UT
DGD1LL6KYLC8
-
Parent
Salt Lake City, UT
DGD1LL6KYLC8
- SAM.gov registration date
- Website
- myriad.com
- Founded
- 1991
- Employees
- 1K-5K
- Estimated annual revenue
- $500M-$1B
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A gene expression based blood test for rheumatic disease diagnosis | National Institutes of Health | $147,000 |
Quick answers
Is Crescendo Bioscience, Inc. registered in SAM.gov?
Crescendo Bioscience, Inc.'s SAM.gov registration expired on December 14, 2021.
What is Crescendo Bioscience, Inc.'s most recent federal award?
Crescendo Bioscience, Inc.'s most recent federal contract award is Rheumatoid arthritis disease activity testing (36C24221F0105), from Veterans Integrated Service Network 2 (VHA), on December 19, 2020.
On GovTribe
See Crescendo Bioscience, Inc.'s full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors